Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitors of p38 kinase and their use disclosed by Scios

Jan. 12, 2001

Centaur's rheumatoid arthritis drug advances to preclinical development

Jan. 12, 2001

New 3-pyridyl-4-arylpyrroles useful for inflammatory and AIDS-related disorders

Jan. 10, 2001

SR Pharma and Corixa broaden autoimmune diseases agreement

Jan. 10, 2001

Amarillo Biosciences reports completion of IFN-alpha phase III trial in Sjogren's syndrome

Jan. 8, 2001

Selective inhibitors of cathepsin S designed jointly by Medivir and Peptimmune

Jan. 8, 2001

Vertex commences phase II trial of VX-745 for rheumatoid arthritis

Jan. 8, 2001

Merck scientists disclose new series of imidazole-based cytokine inhibitors

Jan. 5, 2001

TNF-alpha-inhibitory thiazolopyrimidines patented by group at U. of California

Jan. 5, 2001

Chemokine inhibitors described by Teijin for rheumatoid arthritis and other disorders

Jan. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...